Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 6Prostatic Neoplasms 3Neoplasms 3Motor Activity 3Pancreatic Neoplasms 2Overweight 2Obesity 2Malnutrition 2Lung Neoplasms 2Colorectal Neoplasms 2Weight Loss 1Urinary Bladder Neoplasms 1Taste Disorders 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcopenia 1Rectal Neoplasms 1Patient Compliance 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Metabolic Diseases 1Lymphoma 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Hypertension 1Hypercholesterolemia 1Heart Failure 1Heart Diseases 1Esophageal Neoplasms 1

Interventions

Paclitaxel 69Bevacizumab 62Carboplatin 53pembrolizumab 46olaparib 32Specimen Handling 27Gemcitabine 27Cyclophosphamide 26Magnetic Resonance Spectroscopy 24liposomal doxorubicin 22Cisplatin 21niraparib 20Taxes 18Nivolumab 18fludarabine 17Topotecan 17Biopsy 17Doxorubicin 14Immunoglobulin G 12Fulvestrant 12Disulfides 12Oxaliplatin 10mirvetuximab soravtansine 9durvalumab 9aldesleukin 9Surveys and Questionnaires 9Ipilimumab 9Fluorouracil 9Blood Specimen Collection 9cemiplimab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Nutrition Assessment × 1 year × Clear all
NCT01439659 2026-01-16

Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
75 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡